Vitamin D3 and K2 are taken together because they do two different jobs in the same process: D3 gets calcium into the body, and K2 helps determine where it goes. D3 supports intestinal calcium absorption. Vitamin K then activates two calcium-binding proteins, osteocalcin, which participates in bone mineralisation, and matrix Gla protein, which inhibits calcification in soft tissue including arterial walls. Absorbing more calcium without adequate vitamin K means supporting only half of that system.
That is the rationale, and the biochemistry behind it is well established. What is less well established, and what almost no supplement page will tell you, is that the best randomised trials of MK-7 were both conducted in postmenopausal women, not in men. Extending those results to a 55-year-old man is a reasonable inference, not a demonstrated finding. A dedicated trial designed to answer the question properly is still running.
So the honest summary: sound mechanism, good safety profile, encouraging observational data, promising but limited trial evidence, and an evidence base drawn largely from a different population. D3 and K2 support normal calcium metabolism. They do not treat osteoporosis or heart disease.
What each vitamin actually does
Vitamin D3 and absorption
Vitamin D's central role in calcium handling is to enable absorption across the intestinal wall. Active vitamin D regulates the transport machinery that moves calcium from the gut into the bloodstream. A review in Nutrients covers the mechanisms of vitamin-D-mediated regulation of intestinal calcium absorption in detail.
The practical consequence is that calcium intake and vitamin D status are not independent variables. Without adequate vitamin D, a meaningful portion of dietary calcium passes through unabsorbed. This is why the two are so often paired, and why vitamin D deficiency has knock-on effects for bone regardless of how much calcium you eat.
Vitamin D3, cholecalciferol, is the form made in skin from sunlight and the form generally used in supplements. Deficiency is common, particularly at higher latitudes, in winter, in people with darker skin, and in anyone who spends most daylight hours indoors. It is inexpensive to measure with a blood test, which is a better basis for dosing than guesswork.
Vitamin K and direction
Vitamin K's role is less familiar and more interesting. It is a required cofactor for an enzymatic reaction called gamma-carboxylation, which chemically modifies certain proteins so they can bind calcium. Without vitamin K, those proteins are produced but remain in an under-carboxylated, functionally inactive state.
Two of them matter here:
- Osteocalcin, produced by bone-building cells, participates in the mineralisation of bone matrix.
- Matrix Gla protein, produced in vascular smooth muscle and cartilage, acts as an inhibitor of calcification in soft tissue. When it is properly carboxylated it helps prevent calcium depositing where it should not.
This is reviewed in the British Journal of Nutrition's assessment of the role of menaquinones in human health and in a 2024 Nutrients review of vitamin K, vitamin D, calcium metabolism, and bone health.
The neat way to hold it: D3 opens the door, and K2 decides which room the calcium goes into.
Before you buy anything, read the label
Most labels print a large total in milligrams and leave out the number that decides whether the product does anything, which is how much of the standardised active compound you actually get per serving. The Label Test is the five-point check we use, and it takes about a minute per bottle. It applies to our formulas as much as to anyone else's.
Why MK-7 rather than K1 or MK-4
Vitamin K is a family, not a single compound, and the differences are practically relevant.
Vitamin K1, phylloquinone, comes mostly from leafy green vegetables. It is taken up efficiently by the liver, where it supports the production of clotting factors, but relatively little reaches tissues elsewhere in the body.
Vitamin K2 is a family of menaquinones, designated MK-4 through MK-13, produced by bacterial fermentation and found in fermented foods and some animal products. Natto, fermented soybeans, is the richest dietary source of MK-7.
The relevant comparison was published in Blood, which compared synthetic K1 with natto-derived MK-7 and found MK-7 had a considerably longer half-life and better availability to tissues outside the liver. MK-4, by contrast, has a very short half-life and typically requires much larger and more frequent doses.
Since bone and vascular tissue are precisely the extrahepatic tissues of interest, MK-7 is the form that makes sense in a supplement aimed at bone and cardiovascular support. That is a mechanistic and pharmacokinetic argument, and it is a sound one.
What the human evidence shows, and where it stops
This is the section that matters most, and it is where most content in this category becomes unreliable.
The observational data
The Rotterdam Study, published in the Journal of Nutrition, found that higher dietary menaquinone intake was associated with lower coronary heart disease mortality and less severe aortic calcification.
That is genuinely encouraging and consistent with the mechanism. It is also observational. People with higher menaquinone intake differ from those with lower intake in other ways, and a dietary association in a population cohort cannot establish that taking a capsule changes an individual's outcome.
The randomised trials, and their population
Two randomised controlled trials of MK-7 are usually cited, and both are worth knowing accurately.
A three-year trial published in Osteoporosis International found that low-dose MK-7 supplementation helped decrease bone loss in healthy postmenopausal women. A separate double-blind randomised trial in Thrombosis and Haemostasis found MK-7 supplementation improved arterial stiffness, again in healthy postmenopausal women.
Both are real, properly conducted trials with positive results, and both are the strongest evidence MK-7 has. Both were also conducted in a population that is not men over 45.
This matters, and pretending otherwise would be dishonest. Postmenopausal women experience accelerated bone loss driven by oestrogen withdrawal, a mechanism men do not share. The underlying carboxylation biochemistry is not sex-specific, so extrapolating is reasonable. But reasonable extrapolation is not the same as evidence, and a man buying a K2 supplement should know that the trials behind it were not run in men.
What is still being investigated
A large Danish randomised, double-blind, placebo-controlled trial called InterVitaminK was designed to address vitamin K supplementation and health outcomes in a general population, with the study protocol published in BMJ Open in 2023. Trials like this are how the question gets answered properly.
Meanwhile, a 2021 narrative review in Open Heart characterised vitamin K2 as a neglected player in cardiovascular health where the interventional evidence remains limited. That is the accurate state of play.
The bottom line: the pairing is sensible, safe, and mechanistically well grounded. It is not proven to prevent fractures or cardiac events in men, and nobody should sell it to you as though it were.
The 45+ Essentials
See the full MenhoodLab range in the 45+ Essentials collection, or read the wider picture in heart, circulation, and bones: healthspan basics for men over 45.
Food sources, and practical notes
Vitamin D3: oily fish, egg yolks, and fortified foods, plus skin synthesis from sunlight. Diet alone rarely covers it at higher latitudes in winter, which is why supplementation is common and why testing is useful.
Vitamin K1: leafy greens, especially kale, spinach, broccoli, and Brussels sprouts. Easy to get if you eat vegetables.
Vitamin K2 as MK-7: natto is by far the richest source. Other fermented foods and some cheeses contain smaller amounts. Most Western diets are low in MK-7, which is the main argument for supplementing it rather than K1.
A few practical points:
- Both are fat-soluble. Take them with a meal containing fat for better absorption.
- Vitamin D dosing should follow a blood test where possible rather than a guess. More is not better, and vitamin D toxicity, while uncommon, is real at sustained high doses.
- MK-7 doses in trials have typically ranged from around 180 to 360 micrograms daily.
- Magnesium matters too, since it is involved in vitamin D metabolism.
The interaction that actually matters
Vitamin K directly opposes warfarin and other vitamin K antagonist anticoagulants. That is the entire mechanism of those drugs. Starting a K2 supplement while taking one can destabilise your anticoagulation control, which has real consequences in both directions.
If you take warfarin, acenocoumarol, or phenprocoumon, do not start vitamin K without speaking to the clinician managing your anticoagulation. This is not a precautionary legal footnote, it is a genuine pharmacological interaction. Note that the direct oral anticoagulants, such as apixaban and rivaroxaban, work by a different mechanism and are not vitamin K antagonists, but you should still raise any new supplement with your doctor.
People with kidney disease should also discuss both vitamin D and calcium supplementation with their doctor, since kidney function is central to vitamin D activation and mineral handling.
Frame & Engine
Our bone and cardiovascular formula is built on the mechanism described above: vitamin D3 for absorption, vitamin K2 as MK-7 for calcium routing, plus calcium and BioPerine. See Frame & Engine. Read the evidence section above first, including the note about which population the trials were run in. It supports normal calcium metabolism and bone health, and it is not a treatment for osteoporosis or heart disease.
Related reading: bone density in men over 50, heart health supplements for men over 45, and the cornerstone guide to what changes in a man's body after 45.
If you decide to supplement
Frame & Engine is our daily formula for the calcium routing pair, with D3, K2 as MK-7, and calcium. It supports normal calcium metabolism and bone health. It is not a treatment for osteoporosis or heart disease, and the evidence limits set out above apply to it as much as to any other bottle on the shelf.
A daily formula is judged over eight to twelve weeks, not over a few days, which is a long time to spend on something that might do nothing for you. So it ships as a monthly plan you can cancel at any time, and every order carries a 60-day guarantee. If it does nothing, send it back and we refund it. That is the only promise we are in a position to make.
Frequently asked questions
Why should vitamin D3 and K2 be taken together?
They handle different stages of the same process. Vitamin D3 supports calcium absorption from the intestine, and vitamin K activates the proteins that direct calcium once it is in the body: osteocalcin for bone mineralisation and matrix Gla protein, which inhibits calcification in soft tissue including arteries. Taking D3 alone supports absorption without fully supporting the routing system, which is the rationale for pairing them.
Is the evidence for K2 in men as strong as for women?
No, and this is worth knowing before you buy anything. The two strongest randomised trials of MK-7, a three-year bone loss trial in Osteoporosis International and an arterial stiffness trial in Thrombosis and Haemostasis, were both conducted in healthy postmenopausal women. The underlying carboxylation biochemistry is not sex-specific, so extending the findings to men is a reasonable inference, but it is an inference rather than a demonstrated result. A larger general-population trial, InterVitaminK, is designed to address the question more directly.
What is the difference between K1, MK-4, and MK-7?
K1, phylloquinone, comes mainly from leafy greens and is taken up largely by the liver for clotting factor production. K2 is a family of menaquinones. Research in Blood found natto-derived MK-7 has a considerably longer half-life than K1 and better availability to tissues outside the liver, which is where bone and vascular tissue sit. MK-4 has a much shorter half-life and needs larger, more frequent dosing. MK-7 is therefore the practical choice for bone and cardiovascular formulas.
Does K2 remove calcium from arteries?
No, and that claim goes well beyond the evidence. Vitamin K activates matrix Gla protein, which inhibits soft-tissue calcification, and the Rotterdam Study associated higher dietary menaquinone intake with less aortic calcification. But that is mechanism plus population-level correlation. There is no good evidence that a K2 supplement clears existing arterial calcium or prevents cardiac events, and a 2021 review in Open Heart describes the interventional evidence as still limited.
How much MK-7 should I take?
Trials have generally used somewhere between roughly 180 and 360 micrograms daily. Both vitamins are fat-soluble, so take them with a meal containing fat. For vitamin D specifically, dosing is better guided by a blood test than by guesswork, since deficiency is common but excessive sustained intake carries its own risks.
Can I take K2 with blood thinners?
Not without medical advice. Vitamin K directly opposes warfarin and other vitamin K antagonists, since counteracting vitamin K is how those drugs work. Starting K2 can destabilise your anticoagulation control. Direct oral anticoagulants such as apixaban and rivaroxaban work differently and are not vitamin K antagonists, but you should still tell your doctor about any new supplement.
Can I get enough K2 from food?
It is difficult on a typical Western diet. Natto, fermented soybeans, is by far the richest source of MK-7, and most people do not eat it. Some cheeses and other fermented foods contain smaller amounts. Leafy greens supply K1 rather than K2, and K1 is used mainly by the liver. That gap is the main practical argument for supplementing MK-7 specifically.
References
- Fleet JC. Vitamin D-mediated regulation of intestinal calcium absorption. Nutrients, 2022. PubMed
- Beulens JW, et al. The role of menaquinones (vitamin K2) in human health. Br J Nutr, 2013. PubMed
- Aaseth JO, et al. The importance of vitamin K and the combination of vitamins K and D for calcium metabolism and bone health: a review. Nutrients, 2024. PubMed
- Schurgers LJ, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood, 2007. PubMed
- Geleijnse JM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr, 2004. PubMed
- Knapen MH, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int, 2013. PubMed
- Knapen MH, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thromb Haemost, 2015. PubMed
- Kampmann FB, et al. Study protocol of the InterVitaminK trial. BMJ Open, 2023. PubMed
- Hariri E, et al. Vitamin K2, a neglected player in cardiovascular health: a narrative review. Open Heart, 2021. PubMed
Both of these are worth measuring rather than assuming, and blood tests men over 45 should ask for explains what to ask for and how often to repeat it. For where D3 and K2 sit in a wider routine, see what supplements a man over 45 should take.
This article is for general education and is not medical advice. It is not a substitute for diagnosis or treatment by a qualified clinician. If you take anticoagulant medication or have kidney disease, speak to your doctor before starting vitamin K, vitamin D, or calcium supplements.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.